{"altmetric_id":1449314,"counts":{"readers":{"mendeley":121,"citeulike":1,"connotea":0},"blogs":{"unique_users_count":4,"unique_users":[52536,53136,58719,56568],"posts_count":10},"news":{"unique_users_count":1,"unique_users":["medpage_today"],"posts_count":1},"total":{"posts_count":17},"twitter":{"unique_users_count":3,"unique_users":["hswapnil","uthscsanephro","othinkagain"],"posts_count":4},"wikipedia":{"unique_users_count":1,"unique_users":["en:590920"],"posts_count":1}},"selected_quotes":["Original Gotch Kt\/V paper: (w\/ math expert) HEMO: PD: ADEMEX \/or CANUSA #\u2026","Original Gotch Kt\/V paper: (w\/ math expert) HEMO: PD: ADEMEX \/or CANUSA #NephJCclassics"],"citation":{"abstract":"The effects of the dose of dialysis and the level of flux of the dialyzer membrane on mortality and morbidity among patients undergoing maintenance hemodialysis are uncertain.","abstract_source":"pubmed","altmetric_jid":"4f6fa50e3cf058f6100031c4","authors":["Eknoyan, Garabed","Beck, Gerald J","Cheung, Alfred K","Daugirdas, John T","Greene, Tom","Kusek, John W","Allon, Michael","Bailey, James","Delmez, James A","Depner, Thomas A","Dwyer, Johanna T","Levey, Andrew S","Levin, Nathan W","Milford, Edgar","Ornt, Daniel B","Rocco, Michael V","Schulman, Gerald","Schwab, Steve J","Teehan, Brendan P","Toto, Robert",", ","Garabed Eknoyan","Gerald J. Beck","Alfred K. Cheung","John T. Daugirdas","Tom Greene","John W. Kusek","Michael Allon","James Bailey","James A. Delmez","Thomas A. Depner","Johanna T. Dwyer","Andrew S. Levey","Nathan W. Levin","Edgar Milford","Daniel B. Ornt","Michael V. Rocco","Gerald Schulman","Steve J. Schwab","Brendan P. Teehan","Robert Toto"],"doi":"10.1056\/nejmoa021583","first_seen_on":"2013-05-06T13:09:12+00:00","handles":[],"isbns":[],"issns":["1533-4406","0028-4793"],"issue":"25","journal":"New England Journal of Medicine","last_mentioned_on":1488906000,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12490682","http:\/\/content.nejm.org\/cgi\/pmidlookup?view=short&pmid=12490682&promo=ONFLNS19","http:\/\/dx.doi.org\/10.1056\/NEJMoa021583","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/12490682\/","http:\/\/www.ncbi.nlm.nih.gov\/m\/pubmed\/12490682\/","http:\/\/www.nejm.org\/doi\/full\/10.1056\/NEJMoa021583"],"pmid":"12490682","pubdate":"2002-12-19T00:00:00+00:00","publisher":"Mass Med Soc","publisher_subjects":[{"name":"Medical And Health Sciences","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"subjects":["medicine"],"title":"Effect of dialysis dose and membrane flux in maintenance hemodialysis.","type":"article","volume":"347","mendeley_url":"http:\/\/www.mendeley.com\/research\/effect-dialysis-dose-membrane-flux-maintenance-hemodialysis"},"altmetric_score":{"score":38.61,"score_history":{"1y":5.08,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":38.61},"context_for_score":{"all":{"total_number_of_other_articles":8320311,"mean":7.0122256031246,"rank":237113,"this_scored_higher_than_pct":97,"this_scored_higher_than":8083263,"rank_type":"exact","sample_size":8320311,"percentile":97},"similar_age_3m":{"total_number_of_other_articles":121247,"mean":7.0264856407636,"rank":3790,"this_scored_higher_than_pct":96,"this_scored_higher_than":117457,"rank_type":"exact","sample_size":121247,"percentile":96},"this_journal":{"total_number_of_other_articles":20177,"mean":48.733407117367,"rank":4298,"this_scored_higher_than_pct":78,"this_scored_higher_than":15879,"rank_type":"exact","sample_size":20177,"percentile":78},"similar_age_this_journal_3m":{"total_number_of_other_articles":316,"mean":87.042507936508,"rank":153,"this_scored_higher_than_pct":51,"this_scored_higher_than":163,"rank_type":"exact","sample_size":316,"percentile":51}}},"demographics":{"poster_types":{"member_of_the_public":3},"users":{"twitter":{"cohorts":{"Members of the public":3}},"mendeley":{"by_status":{"Unspecified":1,"Professor > Associate Professor":9,"Researcher":27,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":17,"Student  > Postgraduate":12,"Student  > Master":11,"Other":23,"Student  > Bachelor":8,"Lecturer":2,"Professor":8},"by_discipline":{"Medicine and Dentistry":78,"Social Sciences":2,"Sports and Recreations":1,"Physics and Astronomy":1,"Unspecified":6,"Engineering":6,"Chemistry":2,"Economics, Econometrics and Finance":1,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":12,"Computer Science":3,"Business, Management and Accounting":2,"Nursing and Health Professions":3,"Biochemistry, Genetics and Molecular Biology":3}}},"geo":{"twitter":{"CA":1,"US":1},"mendeley":{"CA":1,"TR":1,"HU":1,"DK":1,"BR":1,"FR":1,"ES":1,"IN":1}}},"posts":{"blogs":[{"title":"Clearance and Kt\/V","url":"http:\/\/renalfellow.blogspot.com\/2010\/12\/clearance-and-ktv.html","license":"public","citation_ids":[1449314],"posted_on":"2010-12-01T09:08:00+00:00","summary":"The complete removal of a substance expressed as volume per unit time is known as clearance. The hemodialysis machine is built to be a urea clearance machine and typical urea clearance rates range from 200-260 ml\/min, far more efficient than the native kid","author":{"name":"Renal Fellow Network","url":"http:\/\/renalfellow.blogspot.com\/","description":"A website written for renal fellows with one new \"Nephrology Teaching Point\" posted on a near daily basis."}},{"title":"Fellow-level lecture on urea kinetics","url":"http:\/\/www.pbfluids.com\/2011\/10\/fellow-level-lecture-on-urea-kinetics.html","license":"public","citation_ids":[1449259,1449314,211265,378150],"posted_on":"2011-10-07T02:16:00+00:00","summary":"I reworked an old lecture from '05 on urea kinetics. The old lecture had a hideous purple background, so changing that to black would have been enough but I added a number of cool touches to fully update it. It worked pretty well, though the end's pacing i","author":{"name":"Precious Bodily Fluids","url":"http:\/\/www.pbfluids.com\/","description":"Musings of a Salt Whisperer"}},{"title":"Volume, a new target for dialysis and acute renal failure?","url":"http:\/\/www.pbfluids.com\/2010\/06\/volume-new-target-for-dialysis-and.html","license":"public","citation_ids":[2124477,1449314,1484628,211330,541553,3320175,2038274],"posted_on":"2010-06-03T04:16:00+00:00","summary":"One of the major advancements in nephrology in the first decade of the 21ast century was the rejection of Kt\/V as a treatment target in dialysis. In a field that is lacking in randomized clinical trials we had three well done randomized clinical trials des","author":{"name":"Precious Bodily Fluids","url":"http:\/\/www.pbfluids.com\/","description":"Musings of a Salt Whisperer"}},{"title":"Do we need to EVOLVE our views on EBM in dialysis","url":"http:\/\/www.pbfluids.com\/2012\/11\/do-we-need-to-evolve-our-views-on-ebm.html","license":"public","citation_ids":[1449259,743098,1449314,1484628,514402,1367879,101315,528002,1039378,424639,1484634],"posted_on":"2012-11-05T18:04:00+00:00","summary":"I have posted on the release of the EVOLVE data at Kidney Week 2012 at the eAJKD blog.This is a big deal and when I read the @NEJM tweet it makes me mad.Cinacalcet doesn\u2019t lower death or major CV event risks in patients undergoing dialysis. nej.md\/U4yeSv #","author":{"name":"Precious Bodily Fluids","url":"http:\/\/www.pbfluids.com\/","description":"Musings of a Salt Whisperer"}},{"title":"NephMadness 2015: Obesity as a Survival Factor in ESRD","url":"http:\/\/ajkdblog.org\/2015\/03\/30\/nephmadness-2015-obesity-as-a-survival-factor-in-esrd\/","citation_ids":[1449314,3871738,1790035,3871742,3871743,3871744],"posted_on":"2015-03-30T12:29:00+00:00","summary":"Sivakumar Sridharan, MBBS, MRCP (UK), PhD, (@sayitmyway) is currently a nephrology fellow at Lister Hospital in Stevenage, UK as part of the North London Nephrology Training Program. Dr. Sridharan received his MBBS from Madras Medical College in Chennai, I","author":{"name":"AJKD Blog","url":"http:\/\/ajkdblog.org\/","description":"The Official Blog of the American Journal of Kidney Diseases"}},{"title":"Survival Analysis With Generalized Additive Models : Part I (background and rationale)","url":"http:\/\/www.r-bloggers.com\/survival-analysis-with-generalized-additive-models-part-i-background-and-rationale\/?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+RBloggers+%28R+bloggers%29","license":"public","citation_ids":[3940337,1449259,3392725,1449314,3962510,541606,23719677,6090394,5106988],"posted_on":"2015-05-01T14:20:00+00:00","summary":"(This article was first published on   Statistical Reflections of a Medical Doctor &raquo; R, and kindly contributed to R-bloggers)      \n\nAfter a really long break, I&rsquo;d will resume my blogging activity. It is actually a full circle for me, since","author":{"name":"R-bloggers","url":"http:\/\/www.r-bloggers.com\/","description":"R news and tutorials contributed by (452) R bloggers"}},{"title":"eKt\/V","url":"http:\/\/renalfellow.blogspot.com\/2011\/03\/ektv.html","license":"public","citation_ids":[1449352,1449259,1449378,1449379,1449314],"posted_on":"2011-03-22T23:22:00+00:00","summary":"As previously discussed on RFN, the single pool Kt\/V (spKt\/V) was developed by Gotch and Sargent in a reanalysis of the NCDS data in an attempt to distinguish the dose of hemodialysis associated with improved outcomes. The spKt\/V model assumes that the hum","author":{"name":"Renal Fellow Network","url":"http:\/\/renalfellow.blogspot.com\/","description":"A website written for renal fellows with one new \"Nephrology Teaching Point\" posted on a near daily basis."}},{"title":"Do you give a Flux about Flux?","url":"http:\/\/www.pbfluids.com\/2016\/05\/do-you-give-flux-about-flux.html","license":"public","citation_ids":[1449314,3245508,7345191,521366],"posted_on":"2016-05-11T16:04:00+00:00","summary":"There is a spirited debate in our hospital system about the use and availability of high flux membranes. Part of the debate centered around middle molecule clearance and its relationship to uremia. I fell back to my old standard the HEMO trial.A study as l","author":{"name":"Precious Bodily Fluids","url":"http:\/\/www.pbfluids.com\/","description":"Musings of a Salt Whisperer"}},{"title":"Decreasing Sudden Deaths in Dialysis: Drugs, Devices, or Dialytic Developments?","url":"https:\/\/ajkdblog.org\/2017\/03\/01\/decreasing-sudden-deaths-in-dialysis-drugs-devices-or-dialytic-developments\/","license":"public","citation_ids":[1367879,4580866,1449314,1484628,16899630,16557863,2027930,16899636,2028069,1974622,3936798,16899644,7472389,16557863],"posted_on":"2017-03-01T17:00:00+00:00","summary":"Nothing seems to work to keep dialysis patients alive longer. Blockbusters like statins and ACE inhibitors have failed in multiple randomized trials in the dialysis population, and even dialysis specific interventions, such as high flux filters or increasi","author":{"name":"AJKD Blog","url":"http:\/\/ajkdblog.org\/","description":"The Official Blog of the American Journal of Kidney Diseases"}},{"title":"#NephMadness 2017: Dialysis Region","url":"https:\/\/ajkdblog.org\/2017\/03\/07\/nephmadness-2017-dialysis-region\/","license":"public","citation_ids":[1449259,4133938,1449314,1484628,211330,3846479,3333561,2093088,6378225,7786799,4282403,1733187,17097845,17097845,423185,15828181,2743845,1883560,17097848,1826886,4841487,15835677,17097850,17097850,211265,229945,17097852,17097854,230051,17097855,17097856,6003666,16056089,2395620,2395620,8161340,236371,6180194,6180194,16752550],"posted_on":"2017-03-07T17:00:00+00:00","summary":"Copyright: Picsfive \/ Shutterstock.com\nSubmit your picks!&nbsp;| NephMadness 2017&nbsp;| #NephMadness&nbsp;or&nbsp;#DialysisRegion\nSelection Committee Member for the Dialysis&nbsp;Region:\n\nJonathan Himmelfarb\nDr.&nbsp;Himmelfarb, MD, is Professor of Medici","author":{"name":"AJKD Blog","url":"http:\/\/ajkdblog.org\/","description":"The Official Blog of the American Journal of Kidney Diseases"}}],"twitter":[{"url":"https:\/\/twitter.com\/hswapnil\/status\/530526863903703043","license":"datasift","citation_ids":[1449314],"posted_on":"2014-11-07T01:07:15+00:00","author":{"name":"Swapnil Hiremath, MD","url":"http:\/\/about.me\/swapnil.hiremath","image":"https:\/\/pbs.twimg.com\/profile_images\/730502747754139649\/hP6Q9DDQ_normal.jpg","description":"Nephrologist, Mumbai|Boston now Ottawa. #NephJC cofounder. Work at @ottawahospital @uottawamed @ottawarenal Opinions personal etc\/No pharma conflicts","id_on_source":"hswapnil","tweeter_id":"23789628","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":3970},"tweet_id":"530526863903703043"},{"url":"http:\/\/twitter.com\/uthscsanephro\/statuses\/643496954429853699","license":"gnip","citation_ids":[1449314],"posted_on":"2015-09-14T18:50:04+00:00","author":{"name":"UTH SA Nephrology","url":"http:\/\/www.ackdjournal.org\/article\/S1548-5595(17)30061-7\/pdf","image":"https:\/\/pbs.twimg.com\/profile_images\/902694810967932928\/hfnyGqMc_normal.jpg","description":"The University of Texas Health San Antonio clinical nephrology fellowship is among the largest in the nation. It is two-years long with several rotations.","id_on_source":"uthscsanephro","tweeter_id":"3436767789","geo":{"lt":29.42412,"ln":-98.49363,"country":"US"},"followers":872},"tweet_id":"643496954429853699"},{"url":"http:\/\/twitter.com\/hswapnil\/statuses\/699438503365627905","license":"gnip","citation_ids":[1449352,1449314],"posted_on":"2016-02-16T03:41:48+00:00","author":{"name":"Swapnil Hiremath, MD","url":"http:\/\/about.me\/swapnil.hiremath","image":"https:\/\/pbs.twimg.com\/profile_images\/730502747754139649\/hP6Q9DDQ_normal.jpg","description":"Nephrologist, Mumbai|Boston now Ottawa. #NephJC cofounder. Work at @ottawahospital @uottawamed @ottawarenal Opinions personal etc\/No pharma conflicts","id_on_source":"hswapnil","tweeter_id":"23789628","geo":{"lt":45.41117,"ln":-75.69812,"country":"CA"},"followers":3970},"tweet_id":"699438503365627905"},{"url":"http:\/\/twitter.com\/othinkagain\/statuses\/699463348472127489","license":"gnip","rt":["hswapnil"],"citation_ids":[1449352,1449314],"posted_on":"2016-02-16T05:20:32+00:00","author":{"name":"Dr. Doubt","image":"https:\/\/pbs.twimg.com\/profile_images\/651120651030298624\/j6iBJAu8_normal.jpg","id_on_source":"othinkagain","tweeter_id":"2787089534","geo":{"lt":null,"ln":null},"followers":511},"tweet_id":"699463348472127489"}],"wikipedia":[{"title":"Hemodialysis","url":"http:\/\/en.wikipedia.org\/?diff=prev&oldid=226033812#altmetric_citation_2","license":"public","citation_ids":[1449314],"posted_on":"2008-07-16T15:09:43+00:00","summary":"In medicine, hemodialysis, also spelled haemodialysis, is a method that is used to achieve the extracorporeal removal of waste products such as creatinine and urea and free water from the blood when the kidneys are in a state of renal failure.","page_url":"http:\/\/en.wikipedia.org\/?curid=590920","wiki_lang":"en","author":{"name":"RDBrown","url":"http:\/\/en.wikipedia.org\/wiki\/User:RDBrown"}}],"misc":[{"title":"Cold dialysate for cardiac protection","url":"https:\/\/medium.com\/@kidney_boy\/cold-dialysate-for-cardiac-protection-3be221d6b36c","license":"public","citation_ids":[5312130,211265,1714383,1449314,4309147,4523921],"posted_on":"2015-08-27T00:00:00+00:00","summary":"Cold dialysate for cardiac protectionThis month\u2019s CJASNeJC is a randomized controlled trial of cold dialysate and its effect on the heart.The introduction begins by stating that hemodialysis itself causes recurrent ischemic damage to the heart, brain, and","author":{"name":"Joel Topf"}}],"news":[{"title":"DreamRCT: The MAGIK Trial","url":"http:\/\/ct.moreover.com\/?a=22885587696&p=1pl&v=1&x=NalzMEgwRFW6H1VqbT7_yg","license":"public","citation_ids":[1969854,1449314,195536,514402,4580866,3889717,5368245,538431,2983335,4580868,4580869,4580870],"posted_on":"2015-10-02T19:05:31+00:00","summary":"If you had unlimited resources, what nephrology clinical trial would you conduct? That's the big idea behind DreamRCT, a project of UKidney created by Joel Topf, MD, and Jordan Weinstein, MD, in partnership with MedPage Today.","author":{"name":"MedPage Today","url":"http:\/\/www.medpagetoday.com\/","image":"https:\/\/s3.amazonaws.com\/weyland.altmetric.com\/news_sources\/logos\/000\/000\/262\/normal\/Screen_Shot_2016-02-09_at_10.51.03.png?1455015082"}}]}}